sharecast

{{ storiesRelated.title }}

News And Announcements
20 Dec
Silverbullet hit by cyber attack but no client info compromised

AIM-listed Silverbullet said on Monday that it was recently the victim of a cyber attack and that the hackers solicited falsified payments of £365,000 from its corporate bank account.

20 Dec
dl immupharma aim drug discovery development pharmaceutical medicine immu pharma logo
ImmuPharma raises £3.55m to fund research pipeline

Specialist drug discovery and development company ImmuPharma announced subscriptions and a placing to raise £3. 55m on Monday, to fund its research and development pipeline as well as general working capital.

20 Dec
carnival dl cruise ship leisure travel italy venice
Carnival confident in year ahead after Q4 earnings miss

Cruise giant Carnival missed Wall Street expectations on fourth quarter earnings on Monday, with its net losses coming in at $2. 6bn, and adjusted net losses at $2bn, although it did paint a brighter picture of the year ahead.

20 Dec
dl zephyr energy aim exploration production oil gas
Covid delays Zephyr acquisition of North Dakota interests

Rocky Mountains-focussed oil and gas company Zephyr Energy updated the market on the proposed acquisition of non-operated working interests in the Williston Basin of North Dakota on Monday, which was first announced in November with an expected closing date of 22 December.

20 Dec
dl jd wetherspoons pub sign outside drinking
Wetherspoons appoints four employees as directors

Pub chain JD Wetherspoon said on Monday that it has appointed four employees as directors in response to concerns there was not enough pub experience at board level.

20 Dec
dl bluejay mining aim exploration development greenland finland logo
Bluejay Mining gets VAT refund after tribunal decisions

Greenland- and Finland-focussed exploration and development company Bluejay Mining updated the market on the VAT Tribunal and Upper Tribunal appeal made by HMRC on Monday, which was first announced on 15 July.

20 Dec
dl valirx aim pharmaceutica cance therapy developer discovery logo
ValiRx amends longstanding licence deal with Cancer Research Technology

Cancer therapeutics developer ValiRx announced on Monday that it has amended and restated the licence for the VAL201 peptide held by the company from Cancer Research Technology (CRT) to enable a range of sub-licensing options.

20 Dec
dl kistos aim low carbon energy investor logo
Kistos confirms participation in bidding for Total West of Shetland assets

Low-carbon focussed energy producer Kistos confirmed in response to press speculation on Monday that it was participating in a process being run by Total to sell interests in certain of Total's West of Shetland gas assets.

20 Dec
dl helium one global aim helium exploration development rukwa logo
Helium One gets reporting deadline extended as it progresses seismic work

Helium explorer Helium One Global announced progress on its second phase 2D seismic campaign at the wholly-owned Rukwa project on Monday, as well as an extension to its financial reporting deadline.

20 Dec
THG rallies as The Analyst withdraws short recommendation

THG shares rallied on Monday, bucking the overall trend, after The Sunday Times reported that research firm The Analyst had withdrawn its short recommendation on the stock.

20 Dec
dl fireangel safety technology group aim fire angel smoke alarms smoke detectors carbon monoxide safety products logo
FireAngel set for improved performance despite supply issues

Home safety product company FireAngel said in an update on Monday that it was on target to meet market expectations for an adjusted loss before tax for the year ending 31 December, representing a “significant improvement” on 2020.

20 Dec
dl empire metals aim mining miner metal logo
Empire Metals upbeat on review of data from Eclipse project

Exploration and development company Empire Metals updated the market on the Eclipse Gold Project in the Eastern Goldfields of Western Australia on Monday, reporting that a strategic technical review had revisited all data collected over the licence area.

20 Dec
dl futura medical aim pharmaceutical discovery development med3000 topical erection erectile dysfunction treatment gel logo
Futura Medical makes good progress with topical erection gel treatment

Futura Medical updated the market on regulatory and commercial progress for ‘MED3000’, its topical gel formulation for the treatment of erectile dysfunction, on Monday.

20 Dec
dl keywords studios aim video games gaming technical creatice services provider developer logo
Keywords Studios hikes forecasts amid solid second half

Video games technical and creative services provider Keywords Studios updated the market on its trading on Monday, upgrading its expectations for the year amid a solid second-half, following a “strong performance” in the first.

20 Dec
dl marlowe plc aim software services technology business regulatory compliance logo
Marlowe acquires Skill Boosters for initial £5.5m payment

Business software and service provider Marlowe has acquired Skill Boosters, incorporated as Inclusive Learning Limited, it announced on Monday, for initial consideration of £5. 5m.

20 Dec
dl sage group software technology accounting computing office logo wikimedia cc licence ftse 100 min
Sage to buy Brightpearl in £225m deal

Software firm Sage Group has agreed to buy multichannel retail management system Brightpearl for $299 (225m).

20 Dec
dl standard chartered bank banking financial services head office london sign logo ftse 100 min
Standard Chartered fined £46.55m for misreporting liquidity position

The Bank of England has slapped Standard Chartered with a £46. 55m for repeatedly misreporting its liquidity position to the Prudential Regulation Authority.

20 Dec
AstraZeneca-Amgen asthma drug gets US approval

The AstraZeneca-Amgen asthma drug Tezspire has been approved by the US Food and Drug Administration to treat of adult and paediatric patients aged 12 years and older, the two companies said on Monday.

20 Dec
dl bodycote surface coatings logo cast ftse 250 min
Bodycote names Daniel Dayan as chairman

Manufacturing firm Bodycote has appointed Daniel Dayan as non-executive chairman, with effect from 1 January.

20 Dec
dl glaxosmithkline gsk phama pharmaceuticals drugs medicine research development office sign ftse 100 min
Glaxo appoints ex-Tesco boss as chair of new consumer healthcare business

GlaxoSmithKline has appointed former Tesco boss Sir Dave Lewis as chairman of its new consumer healthcare business with effect from 1 January 2022.